Comparing the effectiveness of revascularization interventions with medical therapy in patients with ischemic cardiomyopathy: A systematic review and meta-analysis
- PMID: 30815422
- PMCID: PMC6387802
- DOI: 10.14196/mjiri.32.127
Comparing the effectiveness of revascularization interventions with medical therapy in patients with ischemic cardiomyopathy: A systematic review and meta-analysis
Abstract
Background: Determining the effectiveness of cardiovascular interventions plays an important role in reimbursement decisions, health care pricing, and providing clinical guidance on the use of existing clinical technologies. This study aimed to review and analyze the effectiveness of revascularization interventions (CABG and PCI) compared to medical therapy in patients with ischemic cardiomyopathy. Methods: Different databases were searched up to December 2017. The articles were selected based on inclusion and exclusion criteria. Quality of all studies was evaluated by Jadad score and relevant checklists. The I2 test was used to test heterogeneity. Also, to integrate the results of similar studies, meta-analysis was done using STATA software. Results: A total of 18 studies were included. Based on the random effects model, the overall results of comparing the effectiveness of revascularization interventions with medical therapy were as follow: 38.94 [95% CI: 26.95-50.94, p<0.001, I2 = 99.6%, p<0.001], [75.31, 95% CI: 74.06-76.57, p<0.001, I2= 88.8, p<0.001], and 75.76 [95% CI: 71.99-79.53, p<0.001, I2= 99.2, p<0.001] for cardiac mortality rate, quality of life, and 5-year survival, respectively. Also, in patient satisfaction index, revascularization interventions were shown to be more effective than medical therapy. Conclusion: This study showed that revascularization interventions in all studied indices were more effective than medical therapy. Also, between revascularization interventions, PCI was more effective in cardiovascular mortality and 5-year survival than CABG in terms of quality of life. Moreover, CABG was more effective than PCI. In patient satisfaction index, the results of the 2 included studies were contradictory.
Keywords: Effectiveness; Ischemic cardiomyopathy; Medical therapy; Revascularization.
Similar articles
-
Effectiveness of revascularization interventions compared with medical therapy in patients with ischemic cardiomyopathy: A systematic review protocol.Medicine (Baltimore). 2018 Mar;97(10):e9958. doi: 10.1097/MD.0000000000009958. Medicine (Baltimore). 2018. PMID: 29517703 Free PMC article.
-
[Efficacy comparison of 3 strategies for real-world stable coronary artery disease patients with three-vessel disease].Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Dec 24;45(12):1049-1057. doi: 10.3760/cma.j.issn.0253-3758.2017.12.009. Zhonghua Xin Xue Guan Bing Za Zhi. 2017. PMID: 29325365 Chinese.
-
Preferred Revascularization Strategies in Patients with Ischemic Heart Failure: A Meta-Analysis.Curr Med Sci. 2018 Oct;38(5):776-784. doi: 10.1007/s11596-018-1944-8. Epub 2018 Oct 20. Curr Med Sci. 2018. PMID: 30341512
-
Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era.JAMA Intern Med. 2014 Feb 1;174(2):223-30. doi: 10.1001/jamainternmed.2013.12844. JAMA Intern Med. 2014. PMID: 24296767 Review.
-
Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies.J Am Coll Cardiol. 2013 Oct 15;62(16):1421-31. doi: 10.1016/j.jacc.2013.05.033. Epub 2013 Jun 7. J Am Coll Cardiol. 2013. PMID: 23747787
Cited by
-
Surgical versus interventional coronary revascularization in kidney transplant recipients: a systematic review and meta-analysis.Int Urol Nephrol. 2023 Oct;55(10):2493-2499. doi: 10.1007/s11255-023-03546-9. Epub 2023 Mar 12. Int Urol Nephrol. 2023. PMID: 36906876 Free PMC article.
-
[The value of cytochrome P4502C19 gene assay for anti-platelet therapy after PCI in stable angina patients with left main coronary artery lesions].Nan Fang Yi Ke Da Xue Xue Bao. 2020 Feb 29;40(2):274-278. doi: 10.12122/j.issn.1673-4254.2020.02.21. Nan Fang Yi Ke Da Xue Xue Bao. 2020. PMID: 32376540 Free PMC article. Chinese.
-
Medical therapy versus percutaneous coronary intervention in ischemic heart disease: A cost-effectiveness analysis.Med J Islam Repub Iran. 2020 Nov 16;34:155. doi: 10.47176/mjiri.34.155. eCollection 2020. Med J Islam Repub Iran. 2020. PMID: 33500882 Free PMC article.
References
-
- Marui A. Coronary-artery bypass surgery plus medical therapy is associated with longer survival over 10 years than medical therapy alone in patients with ischaemic cardiomyopathy. Evid Based Med. 2017;22(1):32. - PubMed
-
- Nudi F, Procaccini E, Versaci F, Giordano A, Pinto A, Neri G. et al. Impact of coronary revascularization on the clinical and scintigraphic outlook of patients with myocardial ischemia. j cardivasc med. 2017;18(6):404–9. - PubMed
-
- Shah BR, Velazquez E, Shaw LK, Bart B, O'Connor C, Wagner GS. Revascularization improves survival in ischemic cardiomyopathy regardless of electrocardiographic criteria for prior small-to-medium myocardial infarcts. Am Heart J. 2002;143(1):111–7. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous